1/14/2022 | 3926909709 | PLASTIC PRODUCTS FOR CLINICAL IS FOLLOWING PROTOCOL 53718678RSV2008 NOT FOR SALE, DO NOT CONTAIN OZONE DEPLETING SUBSTANCES: | 12.35 | 253.21 | United States of America | Unknown | REPRESENTATIVE OFFICE OF JANSSEN PHARMACEUTICS N V BELGIUM MOSCOW |
1/20/2022 | 3926909709 | PRODUCTS FROM PLASTIC. MATERIAL OF PRODUCTION: POLYSTYRENE. MANUFACTURING METHOD: FORMING. THE FOLLOWING NAMES AND ARTICLES: | 51.6 | 3706.78 | United States of America | ST PETERSBURG RUSSIA | MIRKA RUS LLC |
1/13/2022 | 3926909709 | PLASTIC PRODUCTS, FOR CLINICAL IS FOLLOWING PROTOCOL 64007957MMY3001, NOT FOR SALE, DO NOT CONTAIN OZONE DEPLETING SUBSTANCES: | 7 | 148.7 | United States of America | Unknown | REPRESENTATIVE OFFICE OF JANSSEN PHARMACEUTICS N V BELGIUM MOSCOW |
1/25/2022 | 3926909709 | PLASTIC PRODUCTS, FOR CLINICAL IS FOLLOWING PROTOCOL 73841937NSC3003, NOT FOR SALE, DO NOT CONTAIN OZONE DEPLETING SUBSTANCES: | 26 | 480.99 | United States of America | Unknown | REPRESENTATIVE OFFICE OF JANSSEN PHARMACEUTICS N V BELGIUM MOSCOW |
1/13/2022 | 3926909709 | PRODUCTS FROM PLASTIC. MATERIAL OF PRODUCTION: POLYSTYRENE. MANUFACTURING METHOD: FORMING. THE FOLLOWING NAMES AND ARTICLES: | 16.7 | 1830.87 | United States of America | ST PETERSBURG RUSSIA | MIRKA RUS LLC |
1/25/2022 | 3926909709 | PLASTIC PRODUCTS, FOR CLINICAL IS FOLLOWING PROTOCOL 64007957MMY3001, NOT FOR SALE, DO NOT CONTAIN OZONE DEPLETING SUBSTANCES: | 7.8 | 199.06 | United States of America | Unknown | REPRESENTATIVE OFFICE OF JANSSEN PHARMACEUTICS N V BELGIUM MOSCOW |